Cervical screening in Australia 2014–2015, Table of contents - Australian Institute of Health and Welfare

Publication
Release Date: 25 May 2017
Author: AIHW

PDF Report (2.2Mb)

Enter the email address where you would like the PDF sent. This address will not be used for any other purpose.

Newer release available

Cervical screening in Australia 2014–2015 presents the latest national statistics monitoring the National Cervical Screening Program, which aims to reduce incidence, morbidity and mortality from cervical cancer. Just over half (56%) of women in the target age group of 20–69 took part in the program, with more than 3.8 million women screening in 2014 and 2015. Cervical cancer incidence for women of all ages remains at an historical low of 7 new cases per 100,000 women, and deaths are also low, historically and by international standards, at 2 deaths per 100,000 women.

ISSN: 1039-3307 (Print) 2205-4855 (PDF)
ISBN: 978-1-76054-133-0
Cat. no: CAN 104
Pages: 110

Findings from this report:

In 2014, 149 women aged 20–69 died from cervical cancer
In 2014–2015, more than 3.8 million women participated in cervical screening. This was 56% of women aged 20–69
In 2014, of the women sent a 27-month reminder letter by a cervical screening register, 32% rescreened within 3 months
11% of women with a negative screen in 2014 rescreened earlier than the recommended 2 years, continuing a downward trend

Preliminary material
- Title & verso title pages
- Contents
- Acknowledgments
- Abbreviations
- Summary
- Report card
Body content
- 1 Introduction
  - 1.1 Cervical cancer
  - 1.2 The primary cause of cervical cancer is HPV
  - 1.3 Cervical cancer is a largely preventable disease
- 2 Moving towards a new National Cervical Screening Program
  - 2.1 Cervical screening from 1991 to 2017
  - 2.2 Cervical screening from 1 December 2017
- 3 Key qualities of the National Cervical Screening Program
  - 3.1 Screening behaviour
  - 3.2 Characteristics of the screening test
  - 3.3 Detection of high-grade abnormalities
  - 3.4 Safety of clinical management guidelines
  - 3.5 Expenditure on cervical screening
- 4 Key cervical cancer outcomes
  - 4.1 Incidence of cervical cancer
  - 4.2 Survival after a diagnosis of cervical cancer
  - 4.3 Prevalence of cervical cancer
  - 4.4 Mortality from cervical cancer
  - 4.5 Burden of cervical cancer
- 5 Cervical screening and cervical cancer outcomes in Indigenous women
  - 5.1 Cervical screening in Indigenous women
  - 5.2 Cervical cancer outcomes in Indigenous women
End matter
- Appendix A: Supporting data tables
  - A1 Participation
  - A2 Rescreening
  - A3 Cytology
  - A4 Histology
  - A5 Cytology–histology correlation
  - A6 Incidence of cervical cancer
  - A7 Mortality from cervical cancer
- Appendix B: National Cervical Screening Program information
  - Performance indicators
  - Standards
- Appendix C: Data sources
  - State and territory cervical screening registers
  - AIHW Australian Cancer Database
  - AIHW National Mortality Database
  - Aboriginal and Torres Strait Islander deaths
  - ABS Population data
  - ABS population data for participation calculations
  - Hysterectomy fractions
  - ABS population data for incidence and mortality calculations
  - AIHW National Hospital Morbidity Database
  - AIHW Disease Expenditure Database
  - Medicare Australia Statistics
- Appendix D: Classifications
  - Age
  - State or territory
  - Remoteness area
  - Socioeconomic group
  - Classification of cervical cancer by histology
- Appendix E: Statistical methods
  - Crude rates
  - Age-specific rates
  - Age-standardised rates
- Glossary
- References
- List of tables
- List of figures
- List of boxes
- Related publications
- Supplementary online data tables

Find reports & statistics by topic

Featured reports

Featured

Cervical screening in Australia 2014–2015

Table of contents

AIHW

Feedback